Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The innate immune system is the body's first line of defense against pathogens, providing a rapid, non-specific response to infection or tissue damage. Unlike the adaptive immune system, it does not confer long-lasting immunity and responds in a generic way to a wide range of threats. Activation occurs within minutes to hours after exposure to antigens or danger signals. The activation process begins when innate immune cells detect pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) using germline-encoded pattern recognition receptors. Major classes of PRRs include Toll-like receptors (TLRs), NOD-like receptors (NLRs), RIG-I-like receptors (RLRs), and cytosolic DNA sensors. Key cells involved are phagocytes such as macrophages, neutrophils, dendritic cells, monocytes, natural killer (NK) cells, and epithelial cells. Activation leads to secretion of cytokines, initiation of inflammatory responses, and activation of the complement system. Pathogens may evade detection by interfering with PRR signaling pathways. Dysregulation can lead to autoimmunity if self-molecules trigger inappropriate activation. Proper regulation ensures rapid response without excessive tissue damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate Immune System Activation.